| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Murlentamab | 3C23-K; GM-102 | Phase 2 Clinical | Lfb Biotechnologies Sas | Colorectal Neoplasms; Genital Neoplasms, Female | Details |

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호



